Expression of osteoprotegerin in placenta and its association with preeclampsia.
<h4>Background</h4>Osteoprotegerin (OPG), a key regulatory factor in bone metabolism, was documented also a potential pro-angiogenic factor, which acts an important role in protecting vascular endothelial cells. Since preeclampsia has gradually been employed to be vascular diseases, we s...
Guardado en:
Autores principales: | Pei Shen, Yunhui Gong, Tao Wang, Yueyue Chen, Jin Jia, Shanshan Ni, Bin Zhou, Yapin Song, Lin Zhang, Rong Zhou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a684c4afa22549acabd9a6885f6501c2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Placenta-derived exosomes: potential biomarkers of preeclampsia
por: Pillay P, et al.
Publicado: (2017) -
Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
por: Reham Z. Hamza, et al.
Publicado: (2021) -
Identification and characterization of Piwi-interacting RNAs in human placentas of preeclampsia
por: Jie He, et al.
Publicado: (2021) -
Author Correction: Identification and characterization of Piwi-interacting RNAs in human placentas of preeclampsia
por: Jie He, et al.
Publicado: (2021) -
Effect of Lovastatin on Serum Osteoprotegerin Level in Type 2 Diabetic Nephropathy
por: N Nezami,, et al.
Publicado: (2012)